Survival RateCell SurvivalDisease-Free SurvivalSurvivalSurvival AnalysisGraft SurvivalTreatment OutcomeRetrospective StudiesTime FactorsKaplan-Meier EstimateNeoplasm StagingProportional Hazards ModelsFollow-Up StudiesAntineoplastic Combined Chemotherapy ProtocolsApoptosisPrognosisCombined Modality TherapyNeoplasm Recurrence, LocalLung NeoplasmsMultivariate AnalysisBreast NeoplasmsAntineoplastic AgentsSignal TransductionProspective StudiesImmunohistochemistryCell Line, TumorTumor Markers, BiologicalRisk FactorsAdenocarcinomaCohort StudiesNeoplasm MetastasisChemotherapy, AdjuvantAge FactorsMice, Inbred C57BLLiver NeoplasmsBrain NeoplasmsPredictive Value of TestsCell ProliferationDisease ProgressionCells, CulturedCisplatinLymphatic MetastasisRecurrenceRegistriesNeoplasmsCarcinoma, Non-Small-Cell LungMutationFluorouracilTransplantation, HomologousDoxorubicinCyclophosphamideColorectal NeoplasmsCarcinoma, Squamous CellGene Expression Regulation, NeoplasticRisk AssessmentGraft RejectionSurvival of Motor Neuron 1 ProteinDisease Models, AnimalDrug Administration ScheduleVincristineActuarial AnalysisMice, KnockoutRemission InductionLiver TransplantationPancreatic NeoplasmsKidney TransplantationRadiotherapy, AdjuvantNeoplasm InvasivenessReproducibility of ResultsReverse Transcriptase Polymerase Chain ReactionLife TablesOvarian NeoplasmsPostoperative ComplicationsCarcinoma, HepatocellularCarcinomaGlioblastomaMelanomaMice, Inbred BALB CDose-Response Relationship, DrugMicrobial ViabilityTissue SurvivalProto-Oncogene ProteinsRNA, MessengerCell DeathModels, BiologicalBlotting, WesternAntibodies, MonoclonalGene Expression ProfilingCell LineSEER ProgramMice, TransgenicReoperationPrednisoneAnalysis of VarianceStomach NeoplasmsBone NeoplasmsPhosphorylationCell DifferentiationMultiple MyelomaUnited States